Carol B. Fox
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation, Neuroscience and Neuropharmacology Research, Chemical synthesis and alkaloids, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation(2005)930 cited
- → (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses(1995)179 cited
- → Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds(1991)141 cited
- → Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors(2006)112 cited
- → 3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation(2005)73 cited
- → In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine(2005)67 cited
- → Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia(2011)52 cited
- → Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A(2009)51 cited
- → Megestrol Acetate and Mirtazapine for the Treatment of Unplanned Weight Loss in the Elderly(2009)44 cited
- → Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain(2011)40 cited